Overview

Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)

Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
To evaluate Drug-drug interaction
Phase:
Phase 1
Details
Lead Sponsor:
Yuhan Corporation
Treatments:
Amlodipine
Chlorthalidone
Telmisartan